BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34093263)

  • 1. Assessment of the Safety Signal for the Abuse Potential of Pregabalin and Gabapentin Using the FAERS Database and Big Data Search Analytics.
    Papazisis G; Spachos D; Siafis S; Pandria N; Deligianni E; Tsakiridis I; Goulas A
    Front Psychiatry; 2021; 12():640264. PubMed ID: 34093263
    [No Abstract]   [Full Text] [Related]  

  • 2. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining big data search analytics and the FDA Adverse Event Reporting System database to detect a potential safety signal of mirtazapine abuse.
    Spachos D; Siafis S; Bamidis P; Kouvelas D; Papazisis G
    Health Informatics J; 2020 Sep; 26(3):2265-2279. PubMed ID: 32026758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
    Vickers-Smith R; Sun J; Charnigo RJ; Lofwall MR; Walsh SL; Havens JR
    Drug Alcohol Depend; 2020 Jan; 206():107709. PubMed ID: 31732295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database.
    Bossard JB; Ponté C; Dupouy J; Lapeyre-Mestre M; Jouanjus E
    Clin Drug Investig; 2016 Sep; 36(9):735-742. PubMed ID: 27300651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.
    Shan D; Zou L; Liu X; Shen Y; Cai Y; Zhang J
    Am J Obstet Gynecol; 2020 Jun; 222(6):564-579.e12. PubMed ID: 31870736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases.
    Petrović NZ; Pejčić AV; Milovanović IR
    Expert Opin Drug Saf; 2024 Jan; 23(1):67-78. PubMed ID: 38062555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.
    Evoy KE; Sadrameli S; Contreras J; Covvey JR; Peckham AM; Morrison MD
    Drugs; 2021 Jan; 81(1):125-156. PubMed ID: 33215352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
    Evoy KE; Peckham AM; Covvey JR; Tidgewell KJ
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S89-S99. PubMed ID: 34396549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of suicidal and self-injurious behavior reports with antiseizure medications in the FDA adverse event database.
    Porwal MH; Razzak AN; Kumar V; Obeidat AZ; Sharma U
    Epilepsy Res; 2024 Jul; 203():107382. PubMed ID: 38761467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How addictive are gabapentin and pregabalin? A systematic review.
    Bonnet U; Scherbaum N
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1185-1215. PubMed ID: 28988943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Evidence on Abuse and Misuse of Gabapentinoids.
    Hägg S; Jönsson AK; Ahlner J
    Drug Saf; 2020 Dec; 43(12):1235-1254. PubMed ID: 32857333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abuse and Misuse of Pregabalin and Gabapentin.
    Evoy KE; Morrison MD; Saklad SR
    Drugs; 2017 Mar; 77(4):403-426. PubMed ID: 28144823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory concerns of gabapentin and pregabalin: What does it mean to the pharmacovigilance systems in developing countries?
    Shrestha S; Palaian S
    F1000Res; 2020; 9():32. PubMed ID: 33728039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism associated with gabapentinoid drugs: A pharmacoepidemiologic study.
    Pacheco-Paez T; Montastruc F; Rousseau V; Chebane L; Lapeyre-Mestre M; Renoux C; Montastruc JL
    Mov Disord; 2020 Jan; 35(1):176-180. PubMed ID: 31633228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
    Liu B; Liu R; Wang L
    Medicine (Baltimore); 2017 Sep; 96(37):e8031. PubMed ID: 28906391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study.
    Antunovic M; Vucinic S; Kotur-Stevuljevic J; Krstic K; Jovic-Stosic J; Kilibarda V; Perkovic-Vukcevic N; Djordjevic S
    Int J Gen Med; 2023; 16():1239-1250. PubMed ID: 37065979
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.